We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · March 25, 2021

Preoperative Serum Albumin-to-Globulin Ratio Is Associated With Survival Outcomes in Patients Treated With Cytoreductive Nephrectomy for mRCC

Translational Andrology and Urology


Additional Info

Translational Andrology and Urology
Prognostic Effect of Preoperative Serum Albumin to Globulin Ratio in Patients Treated With Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
Transl Androl Urol 2021 Feb 01;10(2)609-619, E Laukhtina, B Pradere, D D'Andrea, G Rosiello, S Luzzago, A Pecoraro, C Palumbo, S Knipper, PI Karakiewicz, V Margulis, F Quhal, RS Motlagh, H Mostafaei, K Mori, VM Schuettfort, D Enikeev, SF Shariat

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading